164 related articles for article (PubMed ID: 15805264)
1. Gene amplification is a mechanism of Six1 overexpression in breast cancer.
Reichenberger KJ; Coletta RD; Schulte AP; Varella-Garcia M; Ford HL
Cancer Res; 2005 Apr; 65(7):2668-75. PubMed ID: 15805264
[TBL] [Abstract][Full Text] [Related]
2. Six1 overexpression in mammary cells induces genomic instability and is sufficient for malignant transformation.
Coletta RD; Christensen KL; Micalizzi DS; Jedlicka P; Varella-Garcia M; Ford HL
Cancer Res; 2008 Apr; 68(7):2204-13. PubMed ID: 18381426
[TBL] [Abstract][Full Text] [Related]
3. The Six1 homeoprotein stimulates tumorigenesis by reactivation of cyclin A1.
Coletta RD; Christensen K; Reichenberger KJ; Lamb J; Micomonaco D; Huang L; Wolf DM; Müller-Tidow C; Golub TR; Kawakami K; Ford HL
Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6478-83. PubMed ID: 15123840
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the Six1 homeobox gene in normal mammary gland morphogenesis.
Coletta RD; McCoy EL; Burns V; Kawakami K; McManaman JL; Wysolmerski JJ; Ford HL
BMC Dev Biol; 2010 Jan; 10():4. PubMed ID: 20074369
[TBL] [Abstract][Full Text] [Related]
5. The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling.
Micalizzi DS; Christensen KL; Jedlicka P; Coletta RD; Barón AE; Harrell JC; Horwitz KB; Billheimer D; Heichman KA; Welm AL; Schiemann WP; Ford HL
J Clin Invest; 2009 Sep; 119(9):2678-90. PubMed ID: 19726885
[TBL] [Abstract][Full Text] [Related]
6. Six1 overexpression in ovarian carcinoma causes resistance to TRAIL-mediated apoptosis and is associated with poor survival.
Behbakht K; Qamar L; Aldridge CS; Coletta RD; Davidson SA; Thorburn A; Ford HL
Cancer Res; 2007 Apr; 67(7):3036-42. PubMed ID: 17409410
[TBL] [Abstract][Full Text] [Related]
7. Defining a role for the homeoprotein Six1 in EMT and mammary tumorigenesis.
Radisky DC
J Clin Invest; 2009 Sep; 119(9):2528-31. PubMed ID: 19726879
[TBL] [Abstract][Full Text] [Related]
8. Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition.
McCoy EL; Iwanaga R; Jedlicka P; Abbey NS; Chodosh LA; Heichman KA; Welm AL; Ford HL
J Clin Invest; 2009 Sep; 119(9):2663-77. PubMed ID: 19726883
[TBL] [Abstract][Full Text] [Related]
9. Sineoculis homeobox homolog 1 protein is associated with breast cancer progression and survival outcome.
Jin H; Cui M; Kong J; Cui X; Lin Z; Wu Q; Liu S
Exp Mol Pathol; 2014 Oct; 97(2):247-52. PubMed ID: 25062904
[TBL] [Abstract][Full Text] [Related]
10. SIX1 amplification modulates stemness and tumorigenesis in breast cancer.
Guo L; Li F; Liu H; Kong D; Chen C; Sun S
J Transl Med; 2023 Nov; 21(1):866. PubMed ID: 38031089
[TBL] [Abstract][Full Text] [Related]
11. Genomic amplification of orthodenticle homologue 2 in medulloblastomas.
Boon K; Eberhart CG; Riggins GJ
Cancer Res; 2005 Feb; 65(3):703-7. PubMed ID: 15705863
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle regulation of the human Six1 homeoprotein is mediated by APC(Cdh1).
Christensen KL; Brennan JD; Aldridge CS; Ford HL
Oncogene; 2007 May; 26(23):3406-14. PubMed ID: 17130831
[TBL] [Abstract][Full Text] [Related]
13. Suppression of tumorigenesis and metastasis of hepatocellular carcinoma by shRNA interference targeting on homeoprotein Six1.
Ng KT; Lee TK; Cheng Q; Wo JY; Sun CK; Guo DY; Lim ZX; Lo CM; Poon RT; Fan ST; Man K
Int J Cancer; 2010 Aug; 127(4):859-72. PubMed ID: 20013809
[TBL] [Abstract][Full Text] [Related]
14. Six1 mediates resistance to paclitaxel in breast cancer cells.
Li Z; Tian T; Hu X; Zhang X; Nan F; Chang Y; Lv F; Zhang M
Biochem Biophys Res Commun; 2013 Nov; 441(3):538-43. PubMed ID: 24184484
[TBL] [Abstract][Full Text] [Related]
15. Two distinct amplified regions at 17q11-q21 involved in human primary breast cancer.
Bièche I; Tomasetto C; Régnier CH; Moog-Lutz C; Rio MC; Lidereau R
Cancer Res; 1996 Sep; 56(17):3886-90. PubMed ID: 8752152
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers.
Imam JS; Buddavarapu K; Lee-Chang JS; Ganapathy S; Camosy C; Chen Y; Rao MK
Oncogene; 2010 Sep; 29(35):4971-9. PubMed ID: 20603620
[TBL] [Abstract][Full Text] [Related]
17. Sineoculis homeobox homolog 1 protein as an independent biomarker for gastric adenocarcinoma.
Lv H; Cui A; Sun F; Zhang Y; Li Y; Li L; Lin Z
Exp Mol Pathol; 2014 Aug; 97(1):74-80. PubMed ID: 24866365
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic protein 7 is widely overexpressed in primary breast cancer.
Alarmo EL; Rauta J; Kauraniemi P; Karhu R; Kuukasjärvi T; Kallioniemi A
Genes Chromosomes Cancer; 2006 Apr; 45(4):411-9. PubMed ID: 16419056
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of homeobox gene SIX1 in Hodgkin lymphoma.
Nagel S; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
Oncotarget; 2015 Nov; 6(37):40112-26. PubMed ID: 26473286
[TBL] [Abstract][Full Text] [Related]
20. What's new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease.
Dawkins HJ; Robbins PD; Smith KL; Sarna M; Harvey JM; Sterrett GF; Papadimitriou JM
Pathol Res Pract; 1993 Dec; 189(10):1233-52. PubMed ID: 7910395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
